-
EZ Cap Cy5 Firefly Luciferase mRNA Workflow
2026-09-10
Use one transcript to distinguish mRNA delivery from productive protein expression: Cy5 reveals where the cargo goes, while Firefly Luciferase reports whether it is translated. This dual-readout workflow supports transfection optimization, intracellular trafficking studies, and in vivo bioluminescence imaging with clearer troubleshooting than either modality alone.
-
From Fluorescence to Function in mRNA Delivery
2026-09-09
A thought-leadership guide to using dual-readout mRNA controls to connect particle delivery, intracellular localization, and protein expression. The article explains how ARCA capping and 5-methoxyuridine modification strengthen translational assay design while positioning fluorescence-based validation as a bridge to more predictive mRNA delivery systems.
-
mRNA Lipoplexes as Intravenous Tumour Vaccines
2026-09-09
Hattori and colleagues optimized PEGylation of cationic mRNA lipoplexes to reduce lung accumulation while preserving systemic tumour-vaccine activity. The resulting formulation generated strong anti-OVA antibody and cytotoxic responses and suppressed E.G7-OVA tumour growth in mice, highlighting how carrier composition can balance biodistribution and immunogenicity.
-
ARCA Cy5 EGFP mRNA (5-moUTP) Workflow
2026-09-08
Build a dual-readout assay that separates mRNA delivery from protein translation in mammalian cells. This workflow combines Cy5 tracking, EGFP expression, and carrier comparisons to improve mRNA delivery system research, including macrophage-focused studies.
-
Fluoroalkane Polymers for mRNA Cancer Vaccines
2026-09-08
The reference study developed fluoroalkane-grafted polyethylenimine as a simplified mRNA carrier that combines intracellular delivery with TLR4-associated immune stimulation. In mouse melanoma and colon cancer models, the resulting vaccines enhanced antigen presentation and produced antitumor activity, particularly when neoantigen vaccination was combined with immune checkpoint blockade.
-
HyperScript First-Strand cDNA Synthesis Kit Workflow
2026-09-07
Build a more resilient RNA-to-qPCR workflow for ovarian cancer research, including lncRNA, mRNA, and low-abundance transcript assays. Flexible primer selection and thermally stable reverse transcription help address structured RNA, limited input, and target-specific sensitivity challenges.
-
Ceruletide Workflows for Pancreatic Research
2026-09-07
Ceruletide, also known as Caerulein, provides a defined CCK-receptor stimulus for pancreatic secretion, acinar-cell stress, and gastrointestinal motility experiments. This practical guide connects controlled hormone-challenge workflows with emerging MFGE8-based antifibrotic research while emphasizing preparation, assay selection, and troubleshooting.
-
Methylprednisolone Workflows for Bone Inflammation
2026-09-05
Build reproducible inflammation and glucocorticoid-induced bone-injury models with Methylprednisolone, from macrophage cytokine assays to femoral-head imaging. The workflow pairs pathway-level measurements with osteoclast, vascular, histological, and micro-CT endpoints for stronger translational interpretation.
-
Topotecan: From Topo I Mechanism to Translation
2026-09-04
Topotecan, also known as SKF104864, is more than a cytotoxic screening reagent: it is a controllable perturbation of replication-associated DNA damage. This thought-leadership guide connects Topo I biology with assay design, combination strategy, ovarian cancer evidence, glioma research, and pediatric tumor translation.
-
Dual SMAD/Wnt Inhibition for iPSC-RGC Models
2026-09-04
The reference study presents a chemically defined, non-genetic strategy for directing induced pluripotent stem cells toward retinal ganglion cells through coordinated SMAD and canonical Wnt inhibition. Its reproducible yield and antibody-based enrichment address major bottlenecks in glaucoma modeling, while also providing a framework for evaluating RGC biology across iPSC lines.
-
Etoposide (VP-16) for DNA Damage Assays
2026-09-03
Etoposide (VP-16) provides a controllable way to induce topoisomerase II–linked DNA damage, apoptosis, and genome-stability phenotypes. This guide connects practical cell-based workflows with the nuclear cGAS–TRIM41–ORF2p findings of a recent reference study, while emphasizing dose selection, controls, and troubleshooting.
-
VE-822: From ATR Biology to Radiosensitizer Strategy
2026-09-03
VE-822 illustrates how selective ATR inhibition can convert replication stress into a therapeutic vulnerability, particularly when combined with radiation or gemcitabine in pancreatic cancer models. The next translational advantage will come from pairing compound potency with 2D, 3D, and context-aware experimental design.
-
Polygodial for TRPA1 Channel Assays
2026-09-02
Polygodial provides a practical chemical entry point for connecting TRPA1 activation with calcium dynamics, NFAT signaling, and inflammatory outputs. This guide translates epithelial-channel findings into controlled workflows for sensory neuron ion channel studies, neurophysiology research, and mechanistic assay troubleshooting.
-
PAD4-IN-2 TFA: Assay Design for Tumor Models
2026-09-02
PAD4-IN-2 TFA, also known as Compound 5i TFA, enables a tumor-targeted approach to studying PAD4, histone H3 citrullination, and NET biology. This guide focuses on assay architecture, orthogonal validation, and translational interpretation rather than repeating a general product overview.
-
Butylated Hydroxyanisole (BHA) in Redox Assays
2026-09-01
Butylated hydroxyanisole (BHA) is a practical redox perturbation tool for separating oxidative chemistry from assay artifacts. This guide shows how to prepare fresh solutions, design ROS and cell-protection controls, and translate peptide-receptor lessons into more reliable oxidative stress research.